The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

Patrizia Cavazzoni, formerly the top regulator of the drug division of the FDA, will join Pfizer as chief medical officer.

After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., ...

Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

HHS secretary RFK Jr. said that he would “shut the revolving door to reestablish public trust” in the department.

Revolving door is a VERY polite term for Patrizia Cavazzoni's moves. Then again, she has a 25-year history of picking Big ...

Pfizer Inc. appointed the Food and Drug Administration’s former top drug reviewer to serve as its chief medical officer.

Pfizer (PFE) announced that Patrizia Cavazzoni will rejoin the company as Chief Medical Officer. Cavazzoni was most recently Director of the ...

Pfizer Inc. has announced that Patrizia Cavazzoni, M.D. will rejoin the company as Chief Medical Officer, Executive Vice ...

Patrizia Cavazzoni, a former high-ranking Food and Drug Administration official who oversaw a large portion of the agency’s drug review work, will join Pfizer as its next chief medical officer ...

Pfizer has appointed former Patrizia Cavazzoni, MD, former director of the FDA's Center for Drug Evaluation and Research, as its new chief medical officer, Bloomberg reported Feb. 24. Dr. Cavazzoni, ...